Serum tryptase levels and markers of renal dysfunction in a population with chronic kidney disease
Abstract
BACKGROUND: Mast cells (MCs) might play a pathogenetic role in renal fibrosis. Tryptase is a marker for activated MCs. Little is known about tryptase levels in the chronic renal disease population. METHODS: We examined serum MC tryptase concentrations in relation to specific laboratory abnormalities in 153 outpatients with chronic kidney disease (CKD) and in 35 hemodialysis (HD) patients. RESULTS: Here we found that tryptase mean values were higher in men than in women (12.4 +/- 7.6 microg/L vs. 10.2 +/- 8.4 microg/L; p<0.05). Tryptase levels were increased in CKD stages 4 and 5 and in HD patients, versus CKD stages 1 and 2: 12.7 +/- 7.3 microg/L, 13.8 +/- 7.8 microg/L, 15 +/- 8.9 microg/L vs. 6.7 +/- 5.1 microg/L (p<0.01). In univariate analysis, in the conservative treatment CKD population, tryptase was positively correlated with urea, creatinine, potassium, uric acid, phosphorus, parathyroid hormone, homocysteine, fibrinogen and proteinuria (p<0.01); tryptase was negatively correlated with calcium, albumin, creatinine clearance, estimated glomerular filtration rate (by abbreviated MDRD equation) and urine creatinine (p<0.01). In HD patients, the only significative correlation found was with systolic blood pressure and diastolic blood pressure (p<0.01). No significant correlations were found between tryptase and other parameters such as albumin, glucose, hemoglobin, leukocytes, immunoglobulins or C-reactive protein. Multiple regression analysis showed estimated glomerular filtration rate and proteinuria to be independent determinants of tryptase. CONCLUSIONS: This is the first study to determine that tryptase levels increase with higher degrees of kidney dysfunction. The association with markers of diminished renal function suggests impaired metabolism or a negative effect of inflammation on glomerular filtration rate. Further studies are required to ascertain the clinical implications of these findings.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Elevated tryptase can be found in chronic kidney disease, obesity, and hematological neoplasms.
“Elevated tryptase can also be found in chronic kidney disease, obesity, and hematological neoplasms.”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [73]
Non-mast-cell disorders can give rise to baseline serum tryptase, such as impaired renal function.
“Non-MC disorders can give rise to bST, such as impaired renal function [73].”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [73]
Cited by
Sorted by citations
Lyons, J. J. (2018) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2018.04.003 · Cited by 179 · see citing works
Human mast cell tryptase in biology and medicine
Vitte, J. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.04.001 · Cited by 152 · see citing works
The serum tryptase test: an emerging robust biomarker in clinical hematology
Valent, P., Sperr, W. R., Sotlar, K., Reiter, A., Akin, C., Gotlib, J., Horny, H.-P., & Arock, M. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2014.955008 · Cited by 83 · see citing works
Inherited and acquired determinants of serum tryptase levels in humans
Lyons, J. J. (2021) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2021.06.019 · Cited by 52 · see citing works
Valent, P., Horny, H.-P., Triggiani, M., & Arock, M. (2011) · International Archives of Allergy and Immunology · doi:10.1159/000323763 · Cited by 50 · see citing works
Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System
Waters, A. M., Park, H. J., Weskamp, A. L., Mateja, A., Kachur, M. E., Lyons, J. J., Rosen, B. J., & Boggs, N. A. (2022) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2021.12.031 · Cited by 46 · see citing works
Hereditary alpha-tryptasemia: a commonly inherited modifier of anaphylaxis
Wu, R., & Lyons, J. J. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01010-1 · Cited by 43 · see citing works
Elevated Serum Tryptase in Non-Anaphylaxis Cases: A Concise Review
Lee, A. Y. S. (2020) · International Archives of Allergy and Immunology · doi:10.1159/000506199 · Cited by 36 · see citing works
Egner, W., Sargur, R., Shrimpton, A., York, M., & Green, K. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12785 · Cited by 31 · see citing works
Vysniauskaite, M., Hertfelder, H.-J., Oldenburg, J., Dreßen, P., Brettner, S., Homann, J., & Molderings, G. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124912 · Cited by 30 · see citing works
Serum tryptase concentration and progression to end‐stage renal disease
Jesky, M. D., Stringer, S. J., Fenton, A., Ng, K. P., Yadav, P., Ndumbo, M., McCann, K., Plant, T., Dasgupta, I., Harding, S. J., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12622 · Cited by 26 · see citing works
Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders
Beyens, M., Toscano, A., Ebo, D., Gülen, T., & Sabato, V. (2023) · Diagnostics · doi:10.3390/diagnostics13243662 · Cited by 22 · see citing works
“Non-MC disorders can give rise to bST, such as impaired renal function [73].”
BackgroundDiminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects
Vos, B. J. P. R., van der Veer, E., van Voorst Vader, P. C., Mulder, A. B., van der Heide, S., Arends, S., Kluin-Nelemans, J. C., de Monchy, J. G. R., van Doormaal, J. J., & Oude Elberink, J. N. G. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.05.047 · Cited by 17 · see citing works
Serum concentrations of mast cell tryptase are reduced in heavy drinkers
Beceiro, C., Campos, J., Valcarcel, M.-A., Fenger, R. V., Lojo, S., Linneberg, A., Vidal, C., & Gonzalez-Quintela, A. (2015) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.12682 · Cited by 9 · see citing works
- Authors
- Sirvent, A. E., González, C., Enríquez, R., Fernández, J., Millán, I., Barber, X., & Amorós, F.
- Affiliations
- Hospital General Universitario de Elche (ES)
- Universitat de Miguel Hernández d'Elx (ES)
- Corresponding author
- Sirvent, Ana Esther
- Venue
- Journal of Nephrology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-05-01
- Volume
- 23
- Issue
- 3
- Pages
- 282-290
- ISSN
- 1121-8428 (ISSN-L)
- 1724-6059
- OpenAlex
- W45745611
- Cited by
- 66
- References
- 0
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 8 · 2020: 3 · 2019: 5 · 2018: 3 · 2017: 3 · 2016: 5 · 2015: 7 · 2014: 4 · 2013: 4 · 2012: 3
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Nephrology (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- serum tryptase, mast cells, chronic kidney disease, hemodialysis, renal dysfunction, estimated glomerular filtration rate, proteinuria, renal fibrosis, sex differences
- MeSH terms
- Adult, Aged, C-Reactive Protein, Chronic Disease, Female, Glomerular Filtration Rate, Humans, Kidney Diseases, Male, Middle Aged, Regression Analysis, Tryptases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review